Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Toyoda

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Biomedicines|December 23, 2023
DysuricemiaAkiyoshi Nakayama, Masafumi Kurajoh, Yu Toyoda, et al.
The FEBS Journal|November 14, 2009
Disruption of N-linked glycosylation enhances ubiquitin-mediated proteasomal degradation of the human ATP-binding cassette transporter ABCG2Hiroshi Nakagawa, Kanako Wakabayashi-Nakao, Ai Tamura, et al.
Journal of Nutritional Science and Vitaminology|August 31, 2025
Investigation of the Inhibitory Effects of Fatty Acid Derivatives on URAT1 Function, a Renal Urate Re-AbsorberYu Toyoda, Hiroki Saito, Hiroshi Hirata, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 12, 2010
Production of cells with targeted integration of gene variants of human ABC transporter for stable and regulated expression using the Flp recombinase systemKanako Wakabayashi-Nakao, Ai Tamura, Shoko Koshiba, et al.
Journal of Pharmaceutical Sciences|May 14, 2011
Ubiquitin-mediated proteasomal degradation of ABC transporters: a new aspect of genetic polymorphisms and clinical impactsHiroshi Nakagawa, Yu Toyoda, Kanako Wakabayashi-Nakao, et al.
Cell Reports|April 5, 2025
Structural basis of urate transport by glucose transporter 9Daiki Matsushita, Yu Toyoda, Yongchan Lee, et al.
FASEB Bioadvances|March 4, 2020
Identification of hepatic NPC1L1 as an NAFLD risk factor evidenced by ezetimibe-mediated steatosis prevention and recoveryYu Toyoda, Tappei Takada, Masakazu Umezawa, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 20, 2011
Acetaminophen-induced hepatotoxicity in a liver tissue model consisting of primary hepatocytes assembling around an endothelial cell networkYu Toyoda, Miho Tamai, Kasumi Kashikura, et al.
Nutrients|March 12, 2022
Identification of Inhibitory Activities of Dietary Flavonoids against URAT1, a Renal Urate Re-Absorber: In Vitro Screening and Fractional Approach Focused on Rooibos LeavesYu Toyoda, Tappei Takada, Hiroki Saito, et al.
Nutrients|August 23, 2020
Soy Isoflavone Genistein Inhibits an Axillary Osmidrosis Risk Factor ABCC11: In Vitro Screening and Fractional Approach for ABCC11-Inhibitory Activities in Plant Extracts and Dietary FlavonoidsHiroki Saito, Yu Toyoda, Hiroshi Hirata, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Biomedicines|December 23, 2023
DysuricemiaAkiyoshi Nakayama, Masafumi Kurajoh, Yu Toyoda, et al.
The FEBS Journal|November 14, 2009
Disruption of N-linked glycosylation enhances ubiquitin-mediated proteasomal degradation of the human ATP-binding cassette transporter ABCG2Hiroshi Nakagawa, Kanako Wakabayashi-Nakao, Ai Tamura, et al.
Journal of Nutritional Science and Vitaminology|August 31, 2025
Investigation of the Inhibitory Effects of Fatty Acid Derivatives on URAT1 Function, a Renal Urate Re-AbsorberYu Toyoda, Hiroki Saito, Hiroshi Hirata, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 12, 2010
Production of cells with targeted integration of gene variants of human ABC transporter for stable and regulated expression using the Flp recombinase systemKanako Wakabayashi-Nakao, Ai Tamura, Shoko Koshiba, et al.
Journal of Pharmaceutical Sciences|May 14, 2011
Ubiquitin-mediated proteasomal degradation of ABC transporters: a new aspect of genetic polymorphisms and clinical impactsHiroshi Nakagawa, Yu Toyoda, Kanako Wakabayashi-Nakao, et al.
Cell Reports|April 5, 2025
Structural basis of urate transport by glucose transporter 9Daiki Matsushita, Yu Toyoda, Yongchan Lee, et al.
FASEB Bioadvances|March 4, 2020
Identification of hepatic NPC1L1 as an NAFLD risk factor evidenced by ezetimibe-mediated steatosis prevention and recoveryYu Toyoda, Tappei Takada, Masakazu Umezawa, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 20, 2011
Acetaminophen-induced hepatotoxicity in a liver tissue model consisting of primary hepatocytes assembling around an endothelial cell networkYu Toyoda, Miho Tamai, Kasumi Kashikura, et al.
Nutrients|March 12, 2022
Identification of Inhibitory Activities of Dietary Flavonoids against URAT1, a Renal Urate Re-Absorber: In Vitro Screening and Fractional Approach Focused on Rooibos LeavesYu Toyoda, Tappei Takada, Hiroki Saito, et al.
Nutrients|August 23, 2020
Soy Isoflavone Genistein Inhibits an Axillary Osmidrosis Risk Factor ABCC11: In Vitro Screening and Fractional Approach for ABCC11-Inhibitory Activities in Plant Extracts and Dietary FlavonoidsHiroki Saito, Yu Toyoda, Hiroshi Hirata, et al.
Pageof 8